GCP
BSTC

GSA Capital Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

GSA Capital Partners’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,081
Closed -$287K – 1313
2020
Q1 		$287K Sell
5,081
-2,692
-35% -$153K 0.07% 518
2019
Q4 		$443K Buy
+7,773
New +$412K 0.05% 744
2019
Q3 		– Sell
-9,600
Closed -$573K – 1857
2019
Q2 		$573K Sell
9,600
-1,900
-17% -$120K 0.06% 580
2019
Q1 		$717K Buy
11,500
+4,200
+58% +$278K 0.07% 476
2018
Q4 		$442K Hold
7,300
– – 0.05% 623
2018
Q3 		$427K Sell
7,300
-2,200
-23% -$112K 0.02% 1149
2018
Q2 		$426K Buy
9,500
+4,491
+90% +$193K 0.02% 1226
2018
Q1 		$222K Sell
5,009
-2,200
-31% -$92.4K 0.01% 1436
2017
Q4 		$312K Sell
7,209
-1,200
-14% -$53.9K 0.02% 1207
2017
Q3 		$391K Sell
8,409
-2,600
-24% -$124K 0.03% 1107
2017
Q2 		$545K Sell
11,009
-21,838
-66% -$1.14M 0.04% 960
2017
Q1 		$1.8M Sell
32,847
-10,500
-24% -$556K 0.1% 307
2016
Q4 		$2.41M Sell
43,347
-6,800
-14% -$327K 0.14% 150
2016
Q3 		$2.29M Buy
50,147
+6,600
+15% +$265K 0.12% 195
2016
Q2 		$1.74M Sell
43,547
-46,200
-51% -$1.69M 0.1% 302
2016
Q1 		$3.13M Sell
89,747
-1,600
-2% -$58.7K 0.2% 58
2015
Q4 		$3.92M Buy
91,347
+23,500
+35% +$1.18M 0.19% 66
2015
Q3 		$2.95M Buy
67,847
+8,100
+14% +$437K 0.15% 124
2015
Q2 		$3.08M Sell
59,747
-3,900
-6% -$166K 0.12% 168
2015
Q1 		$2.49M Buy
63,647
+9,800
+18% +$384K 0.1% 230
2014
Q4 		$2.08M Buy
53,847
+8,400
+18% +$320K 0.15% 138
2014
Q3 		$1.6M Sell
45,447
-4,600
-9% -$135K 0.08% 262
2014
Q2 		$1.35M Buy
50,047
+16,400
+49% +$427K 0.06% 479
2014
Q1 		$872K Buy
33,647
+5,500
+20% +$132K 0.06% 415
2013
Q4 		$610K Buy
28,147
+13,809
+96% +$283K 0.05% 687
2013
Q3 		$279K Buy
+14,338
New +$254K 0.02% 1188

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GSA Capital Partners's BSTC Position: Q2 2020 in Review

GSA Capital Partners sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2020, closing a stake of 5,081 shares — an estimated $287K sold.

GSA Capital Partners first reported a position in BSTC in Q3 2013 and held it in 26 quarters. The position peaked at $3.92M in Q4 2015. 116 funds tracked by Wall St. Rank hold BSTC as of Q2 2020.

  • GSA Capital Partners reported no remaining BioSpecifics Technologies Corp. position as of Q2 2020 after selling out during the quarter.
  • GSA Capital Partners sold 5,081 BioSpecifics Technologies Corp. shares in Q2 2020, an estimated $287K.
  • GSA Capital Partners first reported a position in BioSpecifics Technologies Corp. in Q3 2013 and held it in 26 quarters.
  • GSA Capital Partners's BioSpecifics Technologies Corp. position peaked at $3.92M in Q4 2015.
  • 116 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2020.

Based on GSA Capital Partners's 13F filing for Q2 2020, filed 11 Aug 2020.